Artificial pancreas news: U.K. researchers unveil device, Animas snags Canadian approval of closed-loop system

De Montfort's artificial pancreas--Courtesy De Montfort U.

Two more advances in insulin pump technology this week offer glimpses of what could soon be an actual artificial pancreas, the combination insulin pump and glucose monitor long desired in the diabetes market. Researchers at De Montfort University in the U.K. unveiled an implantable device designed to automatically regulate glucose levels. The scientists, who developed the device over 20 years, are shooting for a 2016 clinical trial for the artificial pancreas. On this side of the Atlantic, Johnson & Johnson's ($JNJ) Animas division won Canadian approval of its closed-loop Vibe system, thought to be a precursor to the artificial pancreas. Here's the U.K. story and the Animas report from FierceMedicalDevices​.

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…